Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

NCT02231320 · clinicaltrials.gov ↗

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Berodual® Respimat® - inhaler

Sponsor

Boehringer Ingelheim